{"id":414395,"date":"2021-01-13T16:04:09","date_gmt":"2021-01-13T21:04:09","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=414395"},"modified":"2021-01-13T16:04:09","modified_gmt":"2021-01-13T21:04:09","slug":"ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/","title":{"rendered":"Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">REHOVOT, Israel and WILMINGTON, Del., Jan.  13, 2021  (GLOBE NEWSWIRE) &#8212; Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today announced that Roni Mamluk, Ph.D., Chief Executive Officer of Ayala, will present at the Noble Capital Markets 17<sup>th<\/sup> Annual Small &amp; Microcap Investor Conference on Wednesday, January 20, 2021 at 1:30 pm ET.<\/p>\n<p>A live webcast of the presentation may be accessed via the Noble conference portal at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Mm6pUglzreQ8qezWdcC53N01UztxbDAUfjThKMQMCpn7ZzXY_XnceR-DSy0AcOO1WQ3Ys9MOnedkZ7uDEEdcVS3K9wRsdcsKdsF7m-GptUuukhTxg4zbbnCEIaeDm4Jx\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">nobleconference.com<\/a>. A recording of the presentation may also be accessed the following day by visiting the Events &amp; Presentations section of Ayala\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1yiJjz-tHhEOd3Cdk6sEOHUDrc6yyctjMTSi9H9s6Z4n2gsHzQy-tw1bzpK6QDRJvrzbszTrgink795ityiO7g05oIlIFKRYxSFnL278KVU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ir.ayalapharma.com<\/a>. An archived replay of the webcast will be available on the website for 90 days following the presentations.<\/p>\n<p>\n        <strong>About Ayala Pharmaceuticals<\/strong><br \/>\n        <br \/>Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations. Ayala\u2019s approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next-generation sequencing to deliver targeted therapies to underserved patient populations. The company has two product candidates under development, AL101 and AL102, targeting the aberrant activation of the Notch pathway with gamma secretase inhibitors to treat a variety of tumors including Adenoid Cystic Carcinoma, Triple Negative Breast Cancer (TNBC), T-cell Acute Lymphoblastic Leukemia (T-ALL), Desmoid Tumors and Multiple Myeloma (MM) (in collaboration with Novartis). Ayala\u2019s lead product candidate, AL101, has received Fast Track Designation and Orphan Drug Designation from the U.S. FDA and is currently in a Phase 2 clinical trial for patients with ACC (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ncKAFroEfFbEO-EGq_BQTn_RtF1uc_42UKI_ygu0hXKY5xwhC80_buvs026AqRtRH4JUnzbMqcnKm5oDig2EVtZ5zKMr5IGaEialw3X1RWY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ACCURACY<\/a>) bearing Notch activating mutations and in a Phase 2 clinical trial for patients with TNBC (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O4l8-1AiCN02Rtd7evtmoVe7USJXUQZiTil9v11p1ncidQ00Tk73Kwk8UuTMTFrsEe0aPa8Y4Xyi44JJwoaMD2Eq9TVklD-jc5-VDbMlKJyY5kXZVUFegjbH6fWoNuLGsOX3_dgI8lmoTW-JY3lUeg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">TENACITY<\/a>) bearing Notch activating mutations and other gene rearrangements. For more information, visit www.ayalapharma.com.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Julie Seidel<br \/>Stern Investor Relations, Inc. <br \/>+1-212-362-1200<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hM9UCKcl-kmtWUytdEdcXrWoLX_RpPuQpev1zxs3ek4UVGHrzxRpyfjo_8Ty9azDfOydjZt5PHufPTc4aCQFnKLqah16B6xE0V1RLXl-hJ4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Julie.seidel@sternir.com<\/a><\/p>\n<p>\n        <strong>Ayala Pharmaceuticals:<\/strong><br \/>\n        <br \/>+1-857-444-0553<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Z3vb8GhERsGngGJ76OvHDEVkEC5weatxRa0Obiznrb31Zwdkah7AiPhCdC7bPKNSy-oph9A8f5yX8xTSasN-kS8bDaAEoRALaiYksOIFoDc=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@ayalapharma.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTUzMyMzOTE4MTk3IzIxOTUwMTI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/c5355965-60cb-4b75-b569-bc6724bc8e27\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>REHOVOT, Israel and WILMINGTON, Del., Jan. 13, 2021 (GLOBE NEWSWIRE) &#8212; Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today announced that Roni Mamluk, Ph.D., Chief Executive Officer of Ayala, will present at the Noble Capital Markets 17th Annual Small &amp; Microcap Investor Conference on Wednesday, January 20, 2021 at 1:30 pm ET. A live webcast of the presentation may be accessed via the Noble conference portal at nobleconference.com. A recording of the presentation may also be accessed the following day by visiting the Events &amp; Presentations section of Ayala\u2019s website at ir.ayalapharma.com. An archived replay of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-414395","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"REHOVOT, Israel and WILMINGTON, Del., Jan. 13, 2021 (GLOBE NEWSWIRE) &#8212; Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today announced that Roni Mamluk, Ph.D., Chief Executive Officer of Ayala, will present at the Noble Capital Markets 17th Annual Small &amp; Microcap Investor Conference on Wednesday, January 20, 2021 at 1:30 pm ET. A live webcast of the presentation may be accessed via the Noble conference portal at nobleconference.com. A recording of the presentation may also be accessed the following day by visiting the Events &amp; Presentations section of Ayala\u2019s website at ir.ayalapharma.com. An archived replay of &hellip; Continue reading &quot;Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-13T21:04:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTUzMyMzOTE4MTk3IzIxOTUwMTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference\",\"datePublished\":\"2021-01-13T21:04:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\\\/\"},\"wordCount\":352,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTUzMyMzOTE4MTk3IzIxOTUwMTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\\\/\",\"name\":\"Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTUzMyMzOTE4MTk3IzIxOTUwMTI=\",\"datePublished\":\"2021-01-13T21:04:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTUzMyMzOTE4MTk3IzIxOTUwMTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTUzMyMzOTE4MTk3IzIxOTUwMTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference - Market Newsdesk","og_description":"REHOVOT, Israel and WILMINGTON, Del., Jan. 13, 2021 (GLOBE NEWSWIRE) &#8212; Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today announced that Roni Mamluk, Ph.D., Chief Executive Officer of Ayala, will present at the Noble Capital Markets 17th Annual Small &amp; Microcap Investor Conference on Wednesday, January 20, 2021 at 1:30 pm ET. A live webcast of the presentation may be accessed via the Noble conference portal at nobleconference.com. A recording of the presentation may also be accessed the following day by visiting the Events &amp; Presentations section of Ayala\u2019s website at ir.ayalapharma.com. An archived replay of &hellip; Continue reading \"Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-13T21:04:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTUzMyMzOTE4MTk3IzIxOTUwMTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference","datePublished":"2021-01-13T21:04:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/"},"wordCount":352,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTUzMyMzOTE4MTk3IzIxOTUwMTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/","name":"Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTUzMyMzOTE4MTk3IzIxOTUwMTI=","datePublished":"2021-01-13T21:04:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTUzMyMzOTE4MTk3IzIxOTUwMTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTUzMyMzOTE4MTk3IzIxOTUwMTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ayala-pharmaceuticals-to-present-at-noble-capital-markets-17th-annual-small-microcap-virtual-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ayala Pharmaceuticals to Present at Noble Capital Markets 17th Annual Small &amp; Microcap Virtual Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/414395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=414395"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/414395\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=414395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=414395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=414395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}